Cargando…
Combatting PDAC with two tumor-targeting small RNAs
Autor principal: | Kasinski, Andrea L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6800264/ https://www.ncbi.nlm.nih.gov/pubmed/31666921 http://dx.doi.org/10.18632/oncotarget.27245 |
Ejemplares similares
-
Fendiline Enhances the Cytotoxic Effects of Therapeutic Agents on PDAC Cells by Inhibiting Tumor-Promoting Signaling Events: A Potential Strategy to Combat PDAC
por: Alhothali, Marwa, et al.
Publicado: (2019) -
The role of survivin in the progression of pancreatic ductal adenocarcinoma (PDAC) and a novel survivin-targeted therapeutic for PDAC
por: Brown, Matthew, et al.
Publicado: (2020) -
Circulating miRNAs as Noninvasive Biomarkers for PDAC Diagnosis and Prognosis in Mexico
por: Álvarez-Hilario, Lissuly Guadalupe, et al.
Publicado: (2023) -
Targeting KRAS in PDAC: A New Way to Cure It?
por: He, Qianyu, et al.
Publicado: (2022) -
DA7R: A 7-Letter Zip Code to Target PDAC
por: Parrasia, Sofia, et al.
Publicado: (2023)